| The prevalence and treatment patterns of diabetes in the Greek population based on real-world data from the nation-wide prescription database S Liatis, GE Dafoulas, C Kani, A Politi, P Litsa, PP Sfikakis, K Makrilakis Diabetes research and clinical practice 118, 162-167, 2016 | 81 | 2016 |
| Systematic review and network meta-analysis of approved medicines for the treatment of idiopathic pulmonary fibrosis A Skandamis, C Kani, SL Markantonis, K Souliotis Journal of drug assessment 8 (1), 55-61, 2019 | 35 | 2019 |
| Biologic treatment for rheumatic disease: real-world big data analysis from the Greek country-wide prescription database PP Sfikakis, VK Bournia, P Sidiropoulos, DT Boumpas, AA Drosos, ... Clin Exp Rheumatol 35 (4), 579-85, 2017 | 25 | 2017 |
| Greek national e-prescribing system: Preliminary results of a tool for rationalizing pharmaceutical use and cost N Polyzos, C Kastanioti, C Zilidis, G Mavridoglou, S Karakolias, P Litsa, ... Glob J Health Sci 8 (10), 55711, 2016 | 22 | 2016 |
| Using big data to assess prescribing patterns in Greece: the case of chronic obstructive pulmonary disease K Souliotis, C Kani, M Papageorgiou, D Lionis, K Gourgoulianis PLoS One 11 (5), e0154960, 2016 | 20 | 2016 |
| Current environment for introducing health technology assessment in Greece C Kani, V Kourafalos, P Litsa International Journal of Technology Assessment in Health Care 33 (3), 396-401, 2017 | 15 | 2017 |
| Monitoring of subcutaneous dalteparin in patients with renal insufficiency under intensive care: an observational study C Kani, SL Markantonis, C Nicolaou, N Maggina Journal of critical care 21 (1), 79-84, 2006 | 13 | 2006 |
| Real world, big data cost of pharmaceutical treatment for rheumatoid arthritis in Greece K Souliotis, C Golna, C Kani, S Nikolaidi, D Boumpas Plos one 14 (12), e0226287, 2019 | 11 | 2019 |
| Drug consumption during the 2004 Olympics: the special Olympic Pharmacy M Skouroliakou, C Kani, S Kompogiorgas, V Kontozamanis International Journal of Clinical Pharmacy 27 (6), 478, 2005 | 10 | 2005 |
| Exploring knowledge and perceptions on generic drugs of final year pharmacy school students in Greece K Souliotis, C Golna, C Kani, S Markantonis Expert Review of Pharmacoeconomics & Outcomes Research 19 (5), 569-574, 2019 | 6 | 2019 |
| End-of-life health-care cost of patients with lung cancer: a retrospective study K Souliotis, C Kani, A Marioli, A Kamboukou, A Prinou, K Syrigos, ... Health Services Research and Managerial Epidemiology 6, 2333392819841223, 2019 | 6 | 2019 |
| Inhibidores de la colinesterasa y memantina en la enfermedad de Alzheimer: revisión sistemática y metaanálisis de ensayos clínicos controlados aleatorizados C Kani, K Papanikolaou, A Pehlivanidis, S Bonovas, ... Alzheimer. Real Invest Demec 42, 32-40, 2009 | 6 | 2009 |
| Olympic and Paralympic Games in Athens: Polyclinic pharmacy wins the medal M Skouroliakou, C Kani EJHP 6, 146-147, 2004 | 5 | 2004 |
| Reducing patient copayment levels for topical and systemic treatments in plaque psoriasis as a case for evidence-based, sustainable pharmaceutical policy change in Greece K Souliotis, C Golna, C Kani, P Litsa Journal of Medical Economics 19 (11), 1021-1026, 2016 | 4 | 2016 |
| PSY15 Striving for Affordable Treatments Within the Greek Environment: Do Epoetin Biosimilars Help? C Kani, P Litsa, E Alexopoulou, M Hatzikou, S Delibasi, M Geitona Value in Health 14 (7), A412-A413, 2011 | 4 | 2011 |
| Systematic Review and Meta-Analysis of the Efficacy and Safety of Metformin and GLP-1 Analogues in Children and Adolescents with Diabetes Mellitus Type 2 E Carydias, A Tasho, C Kani, F Bacopoulou, C Stefanaki, SL Markantonis Children 9 (10), 1572, 2022 | 3 | 2022 |
| SAT0361 Large, Nation-Wide Data Analysis-Derived Estimated Prevalence of Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), and Systemic Sclerosis (SSC) in … P Sfikakis, G Dafoulas, D Boumpas, A Drosos, G Kitas, SN Liossis, ... Annals of the Rheumatic Diseases 74 (Suppl 2), 790-790, 2015 | 3 | 2015 |
| The impact of economic crisis on drug consumption and pharmaceutical expenditure in Greece A Giannakou, C Kani, L Peppou, M Economou, K Souliotis Value in Health 19 (7), A662, 2016 | 2 | 2016 |
| Nation-wide estimated prevalence of diabetes in Greece: Identification of patients with prescribed pharmacological treatment among 94.5% of the total Greek population S Liatis, G Dafoulas, N Tentolouris, A Kokkinos, M Arvanitis, ... Diabetologia 58, S176-S177, 2015 | 2 | 2015 |
| Drug utilization patterns and costs of erythropoiesis-stimulating agents in an outpatient setting in Greece A Papachristos, C Kani, P Litsa, G Valsami, K Souliotis, M Saridi, ... The Consultant Pharmacist® 31 (5), 271-281, 2016 | 1 | 2016 |
